Natixis’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,360
Closed -$193K 1114
2024
Q3
$193K Sell
2,360
-583
-20% -$45K ﹤0.01% 710
2024
Q2
$254K Buy
+2,943
New +$238K ﹤0.01% 675
2024
Q1
Sell
-71,695
Closed -$4.75M 1107
2023
Q4
$4.75M Buy
+71,695
New +$4.97M 0.03% 302
2021
Q1
Sell
-10,022
Closed -$699K 1119
2020
Q4
$699K Buy
+10,022
New +$623K ﹤0.01% 858
2017
Q4
Sell
-7,395
Closed -$374K 987
2017
Q3
$374K Buy
+7,395
New +$344K ﹤0.01% 805
2017
Q2
Sell
-4,800
Closed -$204K 892
2017
Q1
$204K Buy
+4,800
New +$212K ﹤0.01% 886

Other funds holding HQY

Natixis's HQY Position: Q4 2024 in Review

Natixis sold out of HealthEquity (HQY) in Q4 2024, closing a stake of 2,360 shares — an estimated $193K sold.

Natixis first reported a position in HQY in Q1 2017 and held it in 6 quarters. The position peaked at $4.75M in Q4 2023. 441 funds tracked by Wall St. Rank hold HQY as of Q4 2024.

  • Natixis reported no remaining HealthEquity position as of Q4 2024 after selling out during the quarter.
  • Natixis sold 2,360 HealthEquity shares in Q4 2024, an estimated $193K.
  • Natixis first reported a position in HealthEquity in Q1 2017 and held it in 6 quarters.
  • Natixis's HealthEquity position peaked at $4.75M in Q4 2023.
  • 441 funds tracked by Wall St. Rank held HealthEquity as of Q4 2024.

Based on Natixis's 13F filing for Q4 2024, filed 13 Feb 2025.